StonvexLoading…
StonvexStonvexStonvexCore line items from JAKK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $570.67M | $691.04M | $711.56M | $796.19M |
Operating Income | $14.22M | $39.68M | $59.11M | $60.97M |
Net Income | $9.87M | $33.92M | $38.41M | $91.41M |
EPS (Diluted) | $0.86 | $3.14 | $3.48 | $8.86 |
Total Assets | $442.20M | $444.87M | $398.95M | $405.34M |
Total Liabilities | $193.09M | $204.04M | $202.84M | $254.15M |
Cash & Equivalents | $52.20M | $69.94M | $72.35M | $85.30M |
Free Cash Flow OCF − CapEx | $-1.07M | $27.70M | $57.50M | $75.71M |
Shares Outstanding | 11.34M | 11.03M | 10.10M | 9.74M |